Characteristics of the patients used for systemic antibody responses and opsonisation experiments
| Ulcerative colitis | Crohn’s disease | |
|---|---|---|
| *Total number of patients. Age and sex data are for all patients (n = 51). Other data are for patients for whom clinical information was available (n = 46). | ||
| †Mean (range). | ||
| 5-ASA, 5-aminosalicylic acid; IBD, inflammatory bowel disease. | ||
| n* | 27 | 24 |
| Sex (M/F) | 12/15 | 11/13 |
| Age (y)† | 46 (17–74) | 42 (23–72) |
| Duration of disease (y)† | 7.9 (0–24) | 5.8 (0–17) |
| Anatomical distribution | 16 Pancolitis | 9 Colon only |
| 8 Left sided or distal | 2 Ileal only | |
| 11 Ileocolonic | ||
| 5-ASA drugs | 14 | 7 |
| Systemic or local steroids | 4 | 8 |
| Immunosuppressants | 1 | 4 |
| No IBD specific drugs | 6 | 7 |